| pubmed-article:9441520 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9441520 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:9441520 | lifeskim:mentions | umls-concept:C0232940 | lld:lifeskim |
| pubmed-article:9441520 | lifeskim:mentions | umls-concept:C0049713 | lld:lifeskim |
| pubmed-article:9441520 | pubmed:issue | 18 | lld:pubmed |
| pubmed-article:9441520 | pubmed:dateCreated | 1998-1-16 | lld:pubmed |
| pubmed-article:9441520 | pubmed:abstractText | We evaluated the overnight urinary excretion of 6-sulfatoxymelatonin in a group of 347 women (range: 18-69 years). 26 women (range 20-29 years) with normogonadotrophic, hypoestrogenemic amenorrhoea (WHO II) were selected and compared with a group of 26 women menstruating normally (range: 19-30 years) with respect to urinary 6-sulfatoxymelatonin excretion, serum 17 beta-estradiol levels and response to the thyroid releasing hormone (TRH) test. Patients with hyperprolactinemia, hyperandrogenemia, thyroid dysfunction and weight problems were excluded. 6-sulfatoxymelatonin was found to be significantly higher in the amenorrhoeic women than in the controls (p < 0.000001). In the amenorrhoeic patients a statistically significant inverse correlation was found between serum 17 beta-estradiol levels and urinary 6-sulfatoxymelatonin excretion. A positive correlation was obtained between the thyroid stimulation hormone (TSH) value measured at 20 minutes after stimulation and 6-sulfatoxymelatonin excretion. Further clinical research in this field is required to evaluate its clinical impact, especially in patients with secondary amenorrhea. | lld:pubmed |
| pubmed-article:9441520 | pubmed:language | ger | lld:pubmed |
| pubmed-article:9441520 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9441520 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9441520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9441520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9441520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9441520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9441520 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9441520 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9441520 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:9441520 | pubmed:issn | 0043-5325 | lld:pubmed |
| pubmed-article:9441520 | pubmed:author | pubmed-author:LambJJ | lld:pubmed |
| pubmed-article:9441520 | pubmed:author | pubmed-author:SchneebergerC... | lld:pubmed |
| pubmed-article:9441520 | pubmed:author | pubmed-author:HuberJ CJC | lld:pubmed |
| pubmed-article:9441520 | pubmed:author | pubmed-author:SatorM OMO | lld:pubmed |
| pubmed-article:9441520 | pubmed:author | pubmed-author:GruberD MDM | lld:pubmed |
| pubmed-article:9441520 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9441520 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:9441520 | pubmed:volume | 109 | lld:pubmed |
| pubmed-article:9441520 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9441520 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9441520 | pubmed:pagination | 750-2 | lld:pubmed |
| pubmed-article:9441520 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:meshHeading | pubmed-meshheading:9441520-... | lld:pubmed |
| pubmed-article:9441520 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9441520 | pubmed:articleTitle | [6-sulfatoxymelatonin in women with secondary amenorrhea]. | lld:pubmed |
| pubmed-article:9441520 | pubmed:affiliation | Klinische Abteilung für Gynäkologische Endokrinologie und Sterilitätsbehandlung, Universitätsklinik für Frauenheilkunde, AKH Wien, Osterreich. | lld:pubmed |
| pubmed-article:9441520 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9441520 | pubmed:publicationType | English Abstract | lld:pubmed |
